Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice

J Immunol. 2001 May 1;166(9):5578-84. doi: 10.4049/jimmunol.166.9.5578.

Abstract

Inducible costimulator (ICOS) and B7-related protein-1 (B7RP-1) constitute a receptor-ligand pair involved in T cell costimulation. In this study, the stimulatory effects of B7RP-1 on cellular and humoral immune responses were investigated giving mice a construct with the extracellular domain of murine B7RP-1 fused with human IgG1 Fc (B7RP-1-Fc). B7RP-1-Fc stimulated contact hypersensitivity (CH) given near either the time of sensitization or challenge with oxazolone. When given near challenge time, B7RP-1-Fc stimulated CH more than a construct containing the extracellular domain of murine B7.2 and Fc (B7.2-Fc). B7RP-1-Fc increased the number of cells in lymph nodes draining the skin sensitized with oxazolone, especially activated T cells. B7RP-1-Fc also increased the ability of the cells in these lymph nodes to induce CH when transfused into naive mice. B7RP-1-Fc stimulated the production of anti-keyhole limpet hemocyanin (KLH) Ab, increasing anti-KLH IgG, IgG2a, and IgE, whereas B7.2-Fc did not affect this production. B7RP-1-Fc also increased the number of cells in lymph nodes draining the skin immunized with KLH and their production of IFN-gamma, IL-4, and IL-10 in response to KLH. Finally, B7RP-1-Fc increased the presence of eosinophils in the bronchoalveolar lavage and lungs of mice sensitized and challenged with OVA so to mount an asthmatic reaction. B7RP-1-Fc stimulates both cellular and humoral immune responses in vivo by increasing number and function of T and B cells reacting to Ag exposure.

MeSH terms

  • Abatacept
  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Cutaneous
  • Animals
  • Antigens, CD / administration & dosage
  • Antigens, Differentiation / administration & dosage
  • Asthma / immunology
  • B-Lymphocytes / immunology*
  • B7-1 Antigen / administration & dosage
  • B7-1 Antigen / immunology*
  • B7-2 Antigen
  • Bronchoalveolar Lavage Fluid / cytology
  • Bronchoalveolar Lavage Fluid / immunology
  • CTLA-4 Antigen
  • Dermatitis, Contact / immunology
  • Dermatitis, Contact / pathology
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Hemocyanins / administration & dosage
  • Hemocyanins / immunology
  • Humans
  • Immunoconjugates*
  • Immunoglobulin Fc Fragments / administration & dosage
  • Immunoglobulin G / biosynthesis*
  • Inducible T-Cell Co-Stimulator Ligand
  • Injections, Intraperitoneal
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology
  • Lymphocyte Count
  • Membrane Glycoproteins / administration & dosage
  • Mice
  • Mice, Inbred BALB C
  • Oxazolone / administration & dosage
  • Oxazolone / immunology
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / immunology
  • Skin / immunology
  • Skin / pathology
  • Spleen / cytology
  • Spleen / immunology
  • T-Lymphocytes / immunology*

Substances

  • Adjuvants, Immunologic
  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • B7-2 Antigen
  • CD86 protein, human
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cd86 protein, mouse
  • Ctla4 protein, mouse
  • Drug Combinations
  • Immunoconjugates
  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • Inducible T-Cell Co-Stimulator Ligand
  • Membrane Glycoproteins
  • Recombinant Fusion Proteins
  • Oxazolone
  • Abatacept
  • Hemocyanins
  • keyhole-limpet hemocyanin